Bayzed Health Group Inc. (2609 HK) is a Chinese biotechnology company specializing in comprehensive oncology care. Bayzed Health Group is set to list on the Hong Kong Stock Exchange on June 23, 2025. The company offered 133.11 million shares priced at HKD 4.22 each, the low end of its marketed range, to raise HKD 561.71 million (USD 71.56 million). The offering gives the company a market capitalization of USD 708.84 million. Building maintenance firm Green Economy Development reportedly invested HK$11.6 million as a cornerstone investor. Ahead of the listing, shares performed strongly in gray market trading, reportedly opening over 25% above the IPO price.